Maternal obesity impairs specific regulatory pathways in human myometrial arteries

Biology of Reproduction

Volumn 90, Issue 3, 2014, Pages

  Hayward, Christina E ^a,b   Cowley, Elizabeth J ^a,b   Mills, Tracey A ^a,b   Sibley, Colin P ^a,b   Wareing, Mark ^a,b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b ST MARY S HOSPITAL   (United Kingdom)

Author keywords

Body mass index; Myometrium; Nitric oxide; Preeclampsia; Pregnancy; Thromboxane; Vascular

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; ARGIPRESSIN; BRADYKININ; NITRIC OXIDE; NITROPRUSSIDE SODIUM; PROSTANOID RECEPTOR; THROMBOXANE; THROMBOXANE RECEPTOR; VASODILATOR AGENT;

ADIPOSE TISSUE; ADULT; ARTERY; ARTICLE; BODY MASS; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; HYPOTHESIS; IMMUNOHISTOCHEMISTRY; INFANT; MAJOR CLINICAL STUDY; MALE; MATERNAL OBESITY; MYOGRAPHY; MYOMETRIAL ARTERY; OBESITY; PREGNANT WOMAN; PRIORITY JOURNAL; VASCULAR DISEASE;

BODY MASS INDEX; MYOMETRIUM; NITRIC OXIDE; PREECLAMPSIA; PREGNANCY; THROMBOXANE; VASCULAR;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTERIES; BIOPSY; BODY MASS INDEX; BODY WEIGHT; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INDOMETHACIN; MYOMETRIUM; NITRIC OXIDE; OBESITY; PRE-ECLAMPSIA; PREGNANCY; SIGNAL TRANSDUCTION; THROMBOXANES; VASOCONSTRICTION; VASODILATION;

EID: 84899904206     PISSN: 00063363     EISSN: 15297268     Source Type: Journal    
DOI: 10.1095/biolreprod.113.112623     Document Type: Article

References (68)

1. World Health Organization. Obesity: Preventing and Managing the Global Epidemic (Technical Report Series 894). Geneva, Switzerland: World Health Organization; 2000.
2. Finucane MM, Stevens GA, Cowan MJ, Danaei G, Lin JK, Paciorek CJ, Singh GM, Gutierrez HR, Lu Y, Bahalim AN, Farzadfar F, Riley LM, et al. National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants. Lancet 2011; 377:557-567.
3. Chu S, Kim S, Bish C. Prepregnancy obesity prevalence in the United States, 2004-2005. Matern Child Hlth J 2009; 13:614-620.
4. Heslehurst N, Rankin J, Wilkinson JR, Summerbell CD. A nationally representative study of maternal obesity in England, UK: trends in incidence and demographic inequalities in 619323 births, 1989-2007. Int J Obes 2010; 34:420-428.
5. Kanagalingam MG, Forouhi NG, Greer IA, Sattar N. Changes in booking body mass index over a decade: retrospective analysis from a Glasgow Maternity Hospital. Br J Obstet Gynaecol 2005; 112:1431-1433.
6. Kerrigan AM, Kingdon C. Maternal obesity and pregnancy: a retrospective study. Midwifery 2010; 26:138-146.
7. Khashan AS, Kenny LC. The effects of maternal body mass index on pregnancy outcome. Eur J Epidemiol 2009; 24:697-705.
8. Jensen DM, Damm P, Sorensen B, Molsted-Pedersen L, Westergaard JG, Ovesen P, Beck-Nielsen H. Pregnancy outcome and prepregnancy body mass index in 2459 glucose-tolerant Danish women. Am J Obstet Gynecol 2003; 189:239-244.
9. Nohr EA, Bech BH, Davies MJ, Frydenberg M, Henriksen TB, Olsen J. Prepregnancy obesity and fetal death: a study within the Danish National Birth Cohort. Obstet Gynecol 2005; 106:250-259.
10. Hunter S, Robson SC. Adaptation of the maternal heart in pregnancy. Br Heart J 1992; 68:540-543.
11. Burton GJ, Woods AW, Jauniaux E, Kingdom JCP. Rheological andphysiological consequences of conversion of the maternal spiral arteries for uteroplacental blood flow during human pregnancy. Placenta 2009; 30: 473-482.
12. Poston L, McCarthy AL, Ritter JM. Control of vascular resistance in the maternal and feto-placental arterial beds. Pharmacol Ther 1995; 65: 215-239.
13. Ramsay JE, Ferrell WR, Crawford L, Wallace AM, Greer IA, Sattar N. Maternal obesity is associated with dysregulation of metabolic, vascular, and inflammatory pathways. J Clin Endocrinol Metab 2002; 87: 4231-4237.
14. Saravanakumar K, Rao SG, Cooper GM. Obesity and obstetric anaesthesia. Anaesthesia 2006; 61:36-48.
15. Steinberg HO, Chaker H, Leaming R, Johnson A, Brechtel G, Baron AD. Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. J Clin Invest 1996; 97: 2601-2610.
16. Ashworth JR, Warren AY, Baker PN, Johnson IR. Loss of endotheliumdependent relaxation in myometrial resistance arteries in pre-eclampsia. Br J Obstet Gynaecol 1997; 104:1152-1158.
17. Knock GA, Poston L. Bradykinin-mediated relaxation of isolated maternal resistance arteries in normal pregnancy and preeclampsia. Am J Obstet Gynecol 1996; 175:1668-1674.
18. Mackay AP, Berg CJ, Atrash HK. Pregnancy-related mortality from preeclampsia and eclampsia. Obstet Gynecol 2001; 97:533-538.
19. Vatten LJ, Romundstad PR, Holmen TL, Hsieh CC, Trichopoulos D, Stuver SO. Intrauterine exposure to preeclampsia and adolescent blood pressure, body size, and age at menarche in female offspring. Obstet Gynecol 2003; 101:529-533.
20. Irgens HU, Reisaeter L, Irgens LM, Lie RT. Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study. Br Med J 2001; 323:1213-1217.
21. Sattar N, Greer IA. Pregnancy complications and maternal cardiovascular risk: opportunities for intervention and screening? Br Med J 2002; 325: 157-160.
22. Roberts JM, Hubel CA. Is oxidative stress the link in the two-stage model of pre-eclampsia? Lancet 1999; 354:788-789.
23. Bodnar LM, Ness RB, Markovic N, Roberts JM. The risk of preeclampsia rises with increasing prepregnancy body mass index. Ann Epidemiol 2005; 15:475-482.
24. Aalkjaer C, Nilsson H. Vasomotion: cellular background for the oscillator and for the synchronization of smooth muscle cells. Br J Pharmacol 2005; 144:605-616.
25. Nilsson H, Aalkjaer C. Vasomotion: mechanisms and physiological importance. Mol Interv 2003; 3:79-89.
26. Iino M. Regulation of cell functions by Ca2{Thorn} oscillation. In: Ebashi S, Ohtsuki I (eds.), Regulatory Mechanisms of Striated Muscle Contraction, vol. 592. Tokyo, Japan: Springer; 2007:305-312.
27. Sweeney M, Wareing M, Mills TA, Baker PN, Taggart MJ. Characterisation of tone oscillations in placental and myometrial arteries from normal pregnancies and those complicated by pre-eclampsia and growth restriction. Placenta 2008; 29:356-365.
28. Stansberry KB, Shapiro SA, Hill MA, McNitt PM, Meyer MD, Vinik AI. Impaired peripheral vasomotion in diabetes. Diabetes Care 1996; 19: 715-721.
29. Svahn JK, Kirk JS, Llaguna OH, Habib N. Peripheral vascular disease in diabetes. In: Poretsky L (ed.), Principles of Diabetes Mellitus, 2nd ed. New York: Springer; 2010:371-379.
30. Kusinski LC, Baker PN, Sibley CP, Wareing M. In vitro assessment of mouse uterine and fetoplacental vascular function. Reprod Sci 2009; 16: 740-748.
31. Hayward CE, Higgins L, Cowley EJ, Greenwood SL, Mills TA, Sibley CP, Wareing M. Chorionic plate arterial function is altered in maternal obesity. Placenta 2013; 34:281-287.
32. Wareing M, Crocker IP, Warren AY, Taggart MJ, Baker PN. Characterization of small arteries isolated from the human placental chorionic plate. Placenta 2002; 23:400-409.
33. Sabouni MH, Jamal Mustafa S. Effects of adenosine analogs and ouabain on rhythmicity in human coronary artery. Eur J Pharmacol 1989; 168: 271-276.
34. Grbovic L, Jovanovic A, Tulic I. Uterus and endometrium: indomethacin reduces contraction of isolated non-pregnant human uterine artery induced by prostaglandin F2a. Hum Reprod 1996; 11:1998-2002.
35. Hayward CE, Greenwood SL, Sibley CP, Baker PN, Challis JRG, Jones RL. Effect of maternal age and growth on placental nutrient transport: potential mechanisms for teenagers' predisposition to small-for-gestational- age birth? Am J Physiol Endocrinol Metab 2012; 302:E233-E242.
36. Bauer J, Parekh N. Variations in cell signaling pathways for different vasoconstrictor agonists in renal circulation of the rat. Kidney Int 2003; 63:2178-2186.
37. Hall J, Jones TH, Channer KS, Jones RD. Mechanisms of agonist-induced constriction in isolated human mesenteric arteries. Vascul Pharmacol 2006; 44:427-433.
38. Henderson KK, Byron KL. Vasopressin-induced vasoconstriction: two concentration-dependent signaling pathways. J Appl Physiol 2007; 102: 1402-1409.
39. Moore F, Asboth G, Lopez BA. Thromboxane receptor signalling in human myometrial cells. Prostaglandins Other Lipid Mediat 2002; 67: 31-47.
40. Vanhoutte PM, Tang EH. Endothelium-dependent contractions: when a good guy turns bad! J Physiol 2008; 586:5295-5304.
41. Graziani F, Biasucci LM, Cialdella P, Liuzzo G, Giubilato S, Della Bona R, Pulcinelli FM, Iaconelli A, Mingrone G, Crea F. Thromboxane production in morbidly obese subjects. Am J Cardiol 2011; 107: 1656-1661.
42. Fain JN, Madan AK, Hiler ML, Cheema P, Bahouth SW. Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology 2004; 145:2273-2282.
43. Hauner H. Secretory factors from human adipose tissue and their functional role. Proc Nutr Soc 2005; 64:163-169.
44. Ziccardi P, Nappo F, Giugliano G, Esposito K, Marfella R, Cioffi M, D'Andrea F, Molinari AM, Giugliano D. Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year. Circulation 2002; 105: 804-809.
45. Anim-Nyame N, Sooranna SR, Steer PJ, Johnson MR. Longitudinal analysis of maternal plasma leptin concentrations during normal pregnancy and pre-eclampsia. Hum Reprod 2000; 15:2033-2036.
46. Haugen F, Ranheim T, Harsem NK, Lips E, Staff AC, Drevon CA. Increased plasma levels of adipokines in preeclampsia: relationship to placenta and adipose tissue gene expression. Am J Physiol Endocrinol Metab 2006; 290:E326-E333.
47. Korda M, Kubant R, Patton S, Malinski T. Leptin-induced endothelial dysfunction in obesity. Am J Physiol Heart Circ Physiol 2008; 295: H1514-H1521.
48. Kralisch S, Sommer G, Stangl V, Köhler U, Kratzsch J, Stepan H, Faber R, Schubert A, Lössner U, Vietzke A, Bluher M, Stumvoll M, et al. Secretory products from human adipocytes impair endothelial function via nuclear factor jB. Atherosclerosis 2008; 196:523-531.
49. Jensen MD, Haymond MW, Rizza RA, Cryer PE, Miles JM. Influence of body fat distribution on free fatty acid metabolism in obesity. J Clin Invest 1989; 83:1168-1173.
50. Urakawa H, Katsuki A, Sumida Y, Gabazza EC, Murashima S, Morioka K, Maruyama N, Kitagawa N, Tanaka T, Hori Y, Nakatani K, Yano Y, et al. Oxidative stress is associated with adiposity and insulin resistance in men. J Clin Endocrinol Metab 2003; 88:4673-4676.
51. Jarvie E, Hauguel-de-Mouzon S, Nelson SM, Sattar N, Catalano PM, Freeman DJ. Lipotoxicity in obese pregnancy and its potential role in adverse pregnancy outcome and obesity in the offspring. Clin Sci 2010; 119:123-129.
52. Steinberg HO, Tarshoby M, Monestel R, Hook G, Cronin J, Johnson A, Bayazeed B, Baron AD. Elevated circulating free fatty acid levels impair endothelium-dependent vasodilation. J Clin Invest 1997; 100:1230-1239.
53. Myers J, Hall C, Wareing M, Gillham J, Baker P. The effect of maternal characteristics on endothelial-dependent relaxation of myometrial arteries. Eur J Obstet Gynecol Reprod Biol 2006; 124:158-163.
54. Kenny LC, Baker PN, Kendall DA, Randall MD, Dunn WR. Differential mechanisms of endothelium-dependent vasodilator responses in human myometrial small arteries in normal pregnancy and pre-eclampsia. Clin Sci 2002; 103:67-73.
55. Ong SS, Moore RJ, Warren AY, Crocker IP, Fulford J, Tyler DJ, Gowland PA, Baker PN. Myometrial and placental artery reactivity alone cannot explain reduced placental perfusion in pre-eclampsia and intrauterine growth restriction. Br J Obstet Gynaecol 2003; 110:909-915.
56. Mombouli JV, Vanhoutte PM. Endothelial dysfunction: from physiology to therapy. J Mol Cell Cardiol 1999; 31:61-74.
57. Gao YJ, Lu C, Su LY, Sharma AM, Lee RM. Modulation of vascular function by perivascular adipose tissue: the role of endothelium and hydrogen peroxide. Br J Pharmacol 2007; 151:323-331.
58. Greenstein AS, Khavandi K, Withers SB, Sonoyama K, Clancy O, Jeziorska M, Laing I, Yates AP, Pemberton PW, Malik RA, Heagerty AM. Local inflammation and hypoxia abolish the protective anticontractile properties of perivascular fat in obese patients. Circulation 2009; 119: 1661-1670.
59. Van Gaal LF, Mertens IL, De Block CE. Mechanisms linking obesity with cardiovascular disease. Nature 2006; 444:875-880.
60. Sung CP, Arleth AJ, Shikano K, Berkowitz BA. Characterization and function of bradykinin receptors in vascular endothelial cells. J Pharmacol Exp Ther 1988; 247:8-13.
61. Ozkor MA, Murrow JR, Rahman AM, Kavtaradze N, Lin J, Manatunga A, Quyyumi AA. Endothelium-derived hyperpolarizing factor determines resting and stimulated forearm vasodilator tone in health and in disease. Circulation 2011; 123:2244-2253.
62. Briner VA, Tsai P, Schrier RW. Bradykinin: potential for vascular constriction in the presence of endothelial injury. Am J Physiol Renal Physiol 1993; 264:F322-F327.
63. Wilkes BM, Mento PF. Bradykinin-induced vasoconstriction and thromboxane release in perfused human placenta. Am J Physiol Endocrinol Metab 1988; 254:E681-E686.
64. Ungvari Z, Sarkadi-Nagy E, Bagi Z, Szollár L, Koller A. Simultaneously increased TxA2 activity in isolated arterioles and platelets of rats with hyperhomocysteinemia. Arterioscler Thromb Vasc Biol 2000; 20: 1203-1208.
65. Laudańskia T, Kostrzewska A, Akerlund M. Interaction of vasopressin and prostaglandins in the nonpregnant human uterus. Prostaglandins 1984; 27:441-452.
66. Catalano PM, Ehrenberg HM. The short- and long-term implications of maternal obesity on the mother and her offspring. Br J Obstet Gynaecol 2006; 113:1126-1133.
67. Whitaker RC. Predicting preschooler obesity at birth: the role of maternal obesity in early pregnancy. Pediatrics 2004; 114:e29-e36.
68. Steinberger J, Daniels SR. Obesity, insulin resistance, diabetes, and cardiovascular risk in children. Circulation 2003; 107:1448-1453.